Abstract:Purpose: This study aimed to develop and internally validate nomograms for predicting restenosis after endovascular treatment of lower extremity arterial diseases. Materials and Methods: A total of 181 hospitalized patients with lower extremity arterial disease diagnosed for the first time between 2018 and 2019 were retrospectively collected. Patients were randomly divided into a primary cohort (n=127) and a validation cohort (n=54) at a ratio of 7:3. The least absolute shrinkage and selection operator (LASSO) regression was used to optimize the feature selection of the prediction model. Combined with the best characteristics of LASSO regression, the prediction model was established by multivariate Cox regression analysis. The predictive models’ identification, calibration, and clinical practicability were evaluated by the C index, calibration curve, and decision curve. The prognosis of patients with different grades was compared by survival analysis. Internal validation of the model used data from the validation cohort. Results: The predictive factors included in the nomogram were lesion site, use of antiplatelet drugs, application of drug coating technology, calibration, coronary heart disease, and international normalized ratio (INR). The prediction model demonstrated good calibration ability, and the C index was 0.762 (95% confidence interval: 0.691-0.823). The C index of the validation cohort was 0.864 (95% confidence interval: 0.801-0.927), which also showed good calibration ability. The decision curve shows that when the threshold probability of the prediction model is more significant than 2.5%, the patients benefit significantly from our prediction model, and the maximum net benefit rate is 30.9%. Patients were graded according to the nomogram. Survival analysis found that there was a significant difference in the postoperative primary patency rate between patients of different classifications (log-rank p<0.001) in both the primary cohort and the validation cohort. Conclusion: We developed a nomogram to predict the risk of target vessel restenosis after endovascular treatment by considering information on lesion site, postoperative antiplatelet drugs, calcification, coronary heart disease, drug coating technology, and INR. Clinical Impact Clinicians can grade patients after endovascular procedure according to the scores of the nomograms and apply intervention measures of different intensities for people at different risk levels. During the follow-up process, an individualized follow-up plan can be further formulated according to the risk classification. Identifying and analyzing risk factors is essential for making appropriate clinical decisions to prevent restenosis.

Predictive Value Of Plasma Microrna-140-3p For Restenosis In Patients With Lower Extremity Arterial Occlusive Disease Undergoing Interventional Procedures

Diagnostic Value of Circulating Micrornas for In-Stent Restenosis in Patients with Lower Extremity Arterial Occlusive Disease.

Predictive value of miR-636 in patients with acute myocardial infarction undergoing percutaneous coronary intervention and its bioinformatics analysis

Plasma Micrornas As Potential Noninvasive Biomarkers For In-Stent Restenosis

MicroRNA Expression Profiling Analysis and Target Gene Validation in Human Restenosis after Arterial Reconstruction

Predictive Value of Mirna-21 on Coronary Restenosis after Percutaneous Coronary Intervention in Patients with Coronary Heart Disease

MicroRNAs Expression Profiles in Platelet-Derived Exosomes From Coronary In-Stent Restenosis and the Potential Markers

Changes of Mir-130A and ET-1 and Their Predictive Value for In-Stent Restenosis after Percutaneous Coronary Intervention

[Correlation between C-reactive protein to albumin ratio and restenosis after femoral popliteal stenting in patients with lower extremity arteriosclerotic obliterans]

Evaluation of Preprocedural Laboratory Parameters as Predictors of Drug-Eluting Stent Restenosis in Coronary Chronic Total Occlusion Lesions.

Predictive value of miRNA-126 on in-stent restenosis in patients with coronary heart disease: A protocol for meta-analysis and bioinformatics analysis

Predicting and Analyzing Restenosis Risk after Endovascular Treatment in Lower Extremity Arterial Disease: Development and Assessment of a Predictive Nomogram

Relationships between levels of antibody against oxidized low density lipoproteins and restenosis of coronary artery: Risk factor independent from age, sex, bodymass index hypertension, hyperlipemia and smoking history

Elevated serum miR-133a predicts patients at risk of periprocedural myocardial injury after elective percutaneous coronary intervention

[Predictive Value of Serum Beta 2-Microglobulin Level for Recurrent Stenosis or Occlusion in Patients with Lower Limb Ischemia Undergoing Percutaneous Transluminal Angioplasty].

RETRACTED: Changed Expression of Micrornas May Predict Postoperative Atrial Fibrillation in Patients with Cardiac Surgery (retracted Article. See Vol. 25, Pg. 3400, 2021)

MiR-1403 p is Involved in In-Stent Restenosis by Targeting C-Myb and BCL-2 in Peripheral Artery Disease

Predictive values of the platelet to lymphocyte ratio and neutrophil to lymphocyte ratio for drug eluting stent restenosis

Roles of MicroRNAs in Peripheral Artery In-Stent Restenosis after Endovascular Treatment

MiR-223 Levels Predicting Perioperative Bleeding in Off-Pump Coronary Artery Bypass Grafting

Mir-140-3p Is Involved In In-Stent Restenosis By Targeting C-Myb And Bcl-2 In Peripheral Artery Disease